Presented on May 5th, 2023.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about PepGen.
- Jane Larkindale, DPhil, Vice President of Clinical Science
- Stephen Babcock, Senior Clinical Project Manager
- Ashling Holland, Director of Preclinical Development
- Jenny Shoskes, PharmD, Associate Director of Clinical Development